Selective synthesis of 1-substituted 4-chloropyrazolo[3,4-d]pyrimidines.

Strategies for carrying out the reaction of 4,6-dichloropyrimidine-5-carboxaldehyde with various hydrazines to generate 1-substituted 4-chloropyrazolo[3,4-d]pyrimidines in a selective and high-yielding manner are presented. For aromatic hydrazines, the reaction is performed in the absence of an external base, which promotes exclusive hydrazone formation. The hydrazones subsequently cyclize at an elevated temperature to form the desired pyrazolo[3,4-d]pyrimidine products. For aliphatic hydrazines, the reaction sequence proceeds as a single step in the presence of an external base.

[1]  Tobias A. Nigst,et al.  Nucleophilic reactivities of hydrazines and amines: the futile search for the α-effect in hydrazine reactivities. , 2012, The Journal of organic chemistry.

[2]  G. Rummel,et al.  Expanding the Diversity of Allosteric Bcr-Abl Inhibitors† , 2010, Journal of medicinal chemistry.

[3]  T. Webb,et al.  Efficient synthesis of pyrazolopyrimidine libraries. , 2010, Journal of combinatorial chemistry.

[4]  Dhanaji V. Jawale,et al.  Water-mediated one-pot synthetic route for pyrazolo[3,4-b]quinolines , 2010 .

[5]  B. Insuasty,et al.  Preparation of 6-chloropyrazolo[3,4-b]pyridine-5-carbaldehydes by Vilsmeier–Haack reaction and its use in the synthesis of heterocyclic chalcones and dipyrazolopyridines , 2010 .

[6]  L. Toral-Barza,et al.  Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 1-substituent. , 2010, Bioorganic & medicinal chemistry letters.

[7]  N. Brooijmans,et al.  Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent. , 2009, Journal of medicinal chemistry.

[8]  O. Rabal,et al.  Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases* , 2009, The Journal of Biological Chemistry.

[9]  Scott Boyd,et al.  A one step synthesis of 1-alkylpyrazolo[5,4-d]pyrimidines , 2008 .

[10]  B. Insuasty,et al.  Microwave-assisted synthesis of pyrazolo[3,4-d]pyrimidines from 2-amino-4,6-dichloropyrimidine-5-carbaldehyde under solvent-free conditions , 2008 .

[11]  A. Doweyko,et al.  Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[12]  M. Raghavendra,et al.  Traceless solid-phase synthesis and biological evaluation of purine analogs as inhibitors of multidrug resistance protein 4. , 2007, Journal of combinatorial chemistry.

[13]  B. Neustadt,et al.  Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines. , 2007, Bioorganic & medicinal chemistry letters.

[14]  K. Varani,et al.  New strategies for the synthesis of A3 adenosine receptor antagonists. , 2003, Bioorganic & medicinal chemistry.

[15]  A. Loupy,et al.  Microwave assisted solvent-free synthesis of pyrazolo[3,4-b]quinolines and pyrazolo[3,4-c]pyrazoles using p-TsOH , 2001 .

[16]  O. Meth–Cohn,et al.  A versatile new synthesis of quinolines and related fused pyridines , 1979 .